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Evidence suggests that lower serum undercarboxylated osteocalcin (ucOC) may be negatively 
associated with cardiometabolic health. We investigated whether individuals with the largest 
suppression of ucOC following an increase in dietary vitamin K1, exhibit a relative worsening 
of cardiometabolic risk factors.  
Materials and Methods 
Men (n = 20) and women (n = 10) aged 62 ± 10 years participated in a randomised, 
controlled, cross-over study. The primary analysis involved using data obtained from 
participants following a high vitamin K1 diet (HK; 4-week intervention of increased leafy 
green vegetable intake). High and low responders were defined based on the median percent 
reduction (30%) in ucOC following the HK diet. Blood pressure (resting and 24-hour), arterial 
stiffness, plasma glucose and lipid concentrations, and serum OC forms were assessed. 
Results 
Following the HK diet, ucOC and ucOC/tOC were suppressed more (p < 0.01) in high 
responders (41% and 29%) versus low responders (12% and 10%). The reduction in ucOC 
and ucOC/tOC was not associated with changes in blood pressure, arterial stiffness, plasma 
glucose or lipid concentrations in the high responders (p > 0.05).  
Discussion/Conclusion 
Suppression of ucOC via consumption of leafy green vegetables has no negative effects on 




Cardiovascular disease (CVD) is the leading cause of death worldwide [1]. A diet rich in fruit 
and vegetables is an important, non-therapeutic approach to reduce CVD development and 
progression [2, 3]. Evidence suggests that diets rich in green leafy vegetables increase nitric 
oxide bioavailability and can improve vascular health [4, 5]. However, we have previously 
shown that a 4-week dietary intervention involving an increased intake of leafy green 
vegetables, did not reduce blood pressure (BP) or arterial stiffness [6]. One potential 
explanation for the absence of a beneficial effect on BP and arterial stiffness may be related to 
other bioactive components found in leafy green vegetables that concomitantly influence 
vascular health. For example, vitamin K1 is abundant in leafy green vegetables and regulates 
several coagulation factors including vitamin K-dependent proteins (VKDP) [7]. 
One such protein is osteocalcin (OC), a VKDP derived from osteoblasts that exists in two 
forms: carboxylated OC (cOC) and undercarboxylated OC (ucOC) [8-10]. cOC has a high 
affinity to hydroxyapatite within the bone matrix and is therefore thought to reflect bone 
mineralisation [11, 12], whereas ucOC is proposed as the bioactive form of OC in several 
target tissues [13]. Growing evidence suggests an association between OC, in particular total 
OC (tOC) and ucOC with hypertension, vascular calcification, atherosclerosis and CVD 
mortality [14-17]. However, the literature is conflicting and it is unclear whether tOC or its 
isoforms are associated with positive or negative effects on cardiometabolic health [18, 19]. 
We have previously shown that a diet rich in leafy green vegetables, and thus vitamin K1, 
reduces circulating ucOC levels [20].  
The current study was a sub-analysis examining the cardiometabolic implications of ucOC 
suppression following an increased intake of predominantly leafy green vegetables. It was of 
interest to investigate whether a reduction in ucOC levels was correlated with changes in 
cardiometabolic risk factors, and whether this could explain, at least in part, the lack of a 
beneficial effect on blood pressure following an increase in dietary nitrate. Participants from 
the high vitamin K1 intervention were divided into high/low responders based on the 
suppression of ucOC following the intervention. The aim was to determine if a large reduction 
in ucOC (high responders) would be associated with alterations in cardiometabolic risk 




The data for this paper was collected for the Vegetable Intake and Blood Pressure (VIABP) 
study (ACTRN12615000194561). The study was approved by The University of Western 
Australia Human Research Ethics Committee and was completed in accordance with the 
Declaration of Helsinki. Written informed consent was obtained from all participants. The 
study was a randomised, controlled crossover trial and methodology has been described in full 
elsewhere [6]. In brief, middle and older aged (40 to 74 years of age) community dwelling 
men and women with pre-hypertension or untreated grade one hypertension were recruited to 
participate. Each participant received three 4-week dietary interventions, each interspersed 
with a 4-week washout period. The VIABP study was originally designed with the following 
dietary interventions: (1) increased intake of nitrate-rich leafy green vegetables (high nitrate); 
(2) increased intake of nitrate-poor vegetables (low nitrate); and (3) no increase in vegetables 
(control). As vitamin K1 is also found predominately in leafy green vegetables, these three 
dietary interventions have been equated to: (1) high vitamin K1 intake (HK); (2) low vitamin 
K1 intake (LK); and (3) control diet (CON) [20]. Considering the primary aim of this study is 
to examine the association between the suppression of ucOC and cardiometabolic risk factors 
(and given the LK diet did not suppress ucOC), we predominantly considered data from the 
HK intervention. 
Resting BP and pulse wave velocity (PWV) (SphygmoCor XCEL 2012, AtCor Medical Pty. 
Ltd.) were measured pre and post the 4-week dietary intervention, as previously described [6]. 
Ambulatory BP was recorded over a 24-hour period, every 20 minutes during the day and 
every 30 minutes during the night, mean BP was determined for the 24-hour period [6]. 
Plasma concentrations of glucose, triglycerides, total cholesterol, HDL cholesterol and 
calculated LDL cholesterol were analysed by PathWest laboratories (Fiona Stanley Hospital, 
Perth, Australia). Serum tOC was measured by sandwich electrochemiluminescence 
immunoassay using the Roche Cobas N-Mid OC assay (Roche Diagnostics, Mannheim). The 
inter-assay coefficients of variation were 2.3% and 4.8% at levels of 18 and 90 ng/mL, 
respectively. Serum ucOC was determined using the hydroxyapatite binding method 
(Calbiochem) [21]. The inter-assay imprecision for percentage binding of cOC was 8% and 
12% at OC of 100 and 15 ng/mL, respectively. Plasma creatinine was measured at baseline 
and glomerular filtration rate (GFR) was estimated using plasma creatinine levels based on 




All statistical analysis was performed using Statistical Package for the Social Sciences (SPSS 
Inc. Chicago, IL, USA, version 22). Independant samples t-tests were conducted to examine 
OC concentrations between males and females and if characteristics known to influence ucOC 
(BMI, age, vitamin K intake and GFR) were different between the high responders and low 
responders at baseline. Spearman rho correlations were used to assess the relationship 
between pre-intervention OC concentrations and pre-intervention outcome measures. 
Spearman partial correlations were used for the additional adjustments of age and body mass 
index (BMI) as they are strong influencers of ucOC levels [23, 24]. 
When considering post intervention data from the HK diet intervention, participants were 
divided into high responders (suppression of ucOC ≥ median [≥ 30%]) and low responders 
(suppression of ucOC < median [< 30%]), based on the percent change in ucOC. The between 
groups (high versus low responders) effect of the HK diet on changes in OC, vascular and 
metabolic outcomes were assessed using one-way ANOVA. Within groups effects for pre- 
and post-intervention were assessed using paired samples t-tests, as previously reported [20]. 
All data reported as mean ± SEM and statistical analysis was conducted at the 95% 
confidence level of significance (p < 0.05).  
3. Results  
Baseline characteristics are presented in Table 1. Serum tOC, cOC and ucOC levels at pre-
intervention data points were not different between women (n = 10) or men (n = 20) (p > 0.05 
for all, Table 1). With pre-intervention data points combined together, a higher ucOC/tOC 
ratio was associated with lower PWV when adjusted for BMI and age (r = -0.493, p < 0.05). 
A higher concentration of cOC was associated with a higher PWV when adjusted for BMI and 
age (r = .638, p < 0.01). All other pre-intervention correlations were not significant (p > 0.05 
for all, Supplementary Table 1).  
We have previously shown that the HK intervention, but not the LK or CON intervention 
suppressed tOC, ucOC and the ucOC/tOC ratio [20]. In the high responders tOC, ucOC and 
ucOC/tOC were reduced post-intervention compared to pre-intervention, following the 4-
week HK diet (p < 0.001 for all, Table 2). Whilst in the low responders, ucOC (p < 0.001) 
and ucOC/tOC (p < 0.01), as well as resting systolic BP (2%, p < 0.05) were reduced post 
intervention. As expected, the change in ucOC and ucOC/tOC ratio was significantly greater 
in the high responders versus low responders (p < 0.05 for both, Table 2). The change in tOC, 
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cOC, markers of vascular (ambulatory systolic BP, ambulatory diastolic BP, resting systolic 
BP, resting diastolic BP or PWV) and metabolic (glucose, total cholesterol, LDL, HDL or 
triglycerides) health were not significantly different between the low and high responders 
(Table 2). There was no difference in BMI, vitamin K intake, age or estimated GFR (eGFR) 
between the high or low responders at baseline (p > 0.05 for all, Supplementary Table 2).  
Using unadjusted Spearman rho correlation and Spearman partial correlation there was no 
association between the change in ucOC or the ucOC/tOC ratio with the change in any 
cardiometabolic risk factor in the high responders (p > 0.05 for all, Table 3). Using 
unadjusted spearman rho correlation, a positive association was present between the change in 
ucOC and the change in LDL when all participants were combined (i.e. high and low 
responders combined) (p < 0.05, Table 3). When adjusted for age and BMI using Spearman 
partial correlations, a positive correlation was present between the change in ucOC/tOC ratio 
and change in ambulatory diastolic BP when all participants were combined (r = .435, p < 
0.05). In low responders only, there was a strong positive correlation between the change in 
ucOC/tOC ratio and change in glucose levels (r = .793, p < 0.05). All other correlations were 
not significant (p > 0.05 for all, Table 3).  
4. Discussion  
The major finding of this study is that the suppression of ucOC was not associated with 
increased cardiometabolic risk factors, even in individuals who responded the most to the 
intervention (high responders). As such, it appears that the suppression of ucOC following a 
leafy green-rich diet does not impact, either negatively or positively, on cardiometabolic risk 
factors. 
Currently, there are conflicting reports regarding the relationship between OC and blood 
pressure. Some have reported that lower tOC levels are associated with a higher prevalence of 
hypertension in adult men and women [25, 26]. Others however, have described no 
association between tOC and systolic or diastolic BP in adult men and women [27, 28]. As 
cOC and ucOC may have diverse biological functions, the examination of tOC alone, as often 
reported in these studies, limits our understanding of the exact function of each form of OC 
[23, 29]. In the current study, we have examined each form of OC and report that a reduction 
in ucOC and ucOC/tOC ratio via dietary modification is not correlated with changes in BP. 
This is interesting and suggests several possibilities. Firstly, ucOC may simply not have a 
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regulatory role in the maintenance of blood vessel function and BP. Secondly, the HK (leafy 
green rich) diet may regulate other bioactive factors that influence vascular health. For 
example, we have previously shown that the 4-week leafy green-rich diet increased plasma 
nitrate levels [6]. An increase in plasma nitrate enhances the bioavailability of nitric oxide, an 
anti-atherogenic molecule that regulates blood vessel function and BP [4, 30]. ucOC has also 
been implicated as a regulatory factor responsible for the maintenance of blood vessel 
function and BP [19]. Therefore, it is possible that the reduction in ucOC was offset by an 
increase in NO bioavailability. Consequently, cross-talk mechanisms may exist, which may 
explain the lack of changes in BP. This hypothesis should be explored in further mechanistic 
studies. 
ucOC has been established as a regulator of energy homeostasis, at least in animal models 
[31, 32]. A large number of cross-sectional studies in humans show that ucOC is associated 
with metabolic responses and diseases. For example, a reduction in circulating ucOC is 
associated with an increased risk or presence of metabolic disorders, such as metabolic 
syndrome and type 2 diabetes [17]. Lower circulating tOC and ucOC has been associated with 
increased concentrations of blood glucose and triglycerides and decreased levels of HDL [33, 
34]. However, few interventional studies have modified ucOC and examined the effect on 
metabolic outcomes. One study administered a single dose of prednisolone, a glucocorticoid, 
which suppressed circulating tOC and ucOC and also caused a reduction in insulin sensitivity 
and fasting blood glucose [35, 36]. In the current study, despite a 41% reduction in ucOC and 
29% reduction in ucOC/tOC after the HK diet, there were no changes in fasting glucose or 
lipid levels in the high responders. Potential mechanisms for the lack of change are not clear, 
but it may be related to other bioactive components present in green leafy vegtables that can 
caused a compensatory effect and prevented any change in metabolic variables.  
The development of vascular calcification is a process comparable to the development of bone 
within the skeleton. As OC is involved in bone mineralisation within the skeleton, it has also 
been implicated in the development of mineralisation within the vasculature [37, 23]. cOC, is 
the form of OC most involved with bone development in the skeleton, as such, it is possible 
that cOC is the form of OC involved in the development of calcification within the 
vasculature. However, research in this area is lacking. We have shown that baseline cOC is 
associated with baseline PWV, a measure of arterial stiffness which suggests the presence of 
vascular calcificaton [38]. However, we saw no correlation of cOC with PWV following the 
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HK diet in the high or low responders. Whilst, it is possible that OC is involved in vascular 
calcification, future large scale studies are needed to assess the effect of each form of OC, in 
particular cOC, on arterial stiffness and the development of vascular calcification. 
A limitation of the current study is that the 4-week intervention period may not have been 
long enough or the dose of vitamin K1 large enough to observe a change in measures of 
cardiometabolic risk. Previous studies administering vitamin K1 supplementation (500 - 
1000µg p/day) for 3 years found improvements in vascular compliance and reductions in 
coronary artery calcification [39, 40]. In the current study, it was estimated that participants 
increased their vitamin K1 intake by ~150 µg p/day over the 4-weeks [20]. As such, a 
prolonged intervention may be needed to demonstrate changes in cardiometabolic risk factors. 
Another potential limitation was the inclusion of people who are relatively healthy. It is 
possible that those with diabetes or cardiovascular disease will respond differently to the 
intervention and that the correlation between ucOC and cardiovascular risk factors may be 
apparent in these populations. Finally, the generalisation of the results are somewhat limited 
due to the relatively small sample size. As such, further large scale studies, in particular 
RCTs, are needed to confirm our findings.  
In conclusion, this study demonstrated that the suppression of ucOC following increased daily 
intake of leafy green vitamin K1-rich vegetables over 4-weeks was not associated with 
unfavourable changes in cardiometabolic risk factors. This may be due to the presence of 
compensatory mechanisms, or the fact that ucOC has a limited regulatory role over 
cardiometabolic risk factors in apparently healthy individuals. Such hypothesis should be 
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